Immunogenicity and protective efficacy of a novel foot-and-mouth disease virus empty-capsid-like particle with improved acid stability.

[1]  M. Abubakar,et al.  Interplay of foot and mouth disease virus with cell‐mediated and humoral immunity of host , 2018, Reviews in medical virology.

[2]  J. Seago,et al.  Isolation of Single-Domain Antibody Fragments That Preferentially Detect Intact (146S) Particles of Foot-and-Mouth Disease Virus for Use in Vaccine Quality Control , 2017, Front. Immunol..

[3]  K. McCullough,et al.  Preserved immunogenicity of an inactivated vaccine based on foot-and-mouth disease virus particles with improved stability. , 2017, Veterinary microbiology.

[4]  D. Stuart,et al.  SAT2 Foot-and-Mouth Disease Virus Structurally Modified for Increased Thermostability , 2017, Journal of Virology.

[5]  P. Gao,et al.  A Recombinant Adenovirus Expressing P12A and 3C Protein of the Type O Foot-and-Mouth Disease Virus Stimulates Systemic and Mucosal Immune Responses in Mice , 2016, BioMed research international.

[6]  K. Gupta,et al.  The MultiBac Baculovirus/Insect Cell Expression Vector System for Producing Complex Protein Biologics , 2015, Advances in experimental medicine and biology.

[7]  M. Martín-Acebes,et al.  The pH Stability of Foot-and-Mouth Disease Virus Particles Is Modulated by Residues Located at the Pentameric Interface and in the N Terminus of VP1 , 2015, Journal of Virology.

[8]  F. Maree,et al.  Challenges and prospects for the control of foot-and-mouth disease: an African perspective , 2014, Veterinary medicine.

[9]  Decheng Yang,et al.  Single amino acid substitution of VP1 N17D or VP2 H145Y confers acid-resistant phenotype of type Asia1 foot-and-mouth disease virus , 2014, Virologica Sinica.

[10]  K. Fujii,et al.  Receptors for enterovirus 71 , 2014, Emerging Microbes & Infections.

[11]  H. Yamaji.  Suitability and perspectives on using recombinant insect cells for the production of virus-like particles , 2014, Applied Microbiology and Biotechnology.

[12]  M. Martín-Acebes,et al.  An Increase in Acid Resistance of Foot-and-Mouth Disease Virus Capsid Is Mediated by a Tyrosine Replacement of the VP2 Histidine Previously Associated with VP0 Cleavage , 2013, Journal of Virology.

[13]  S. Basagoudanavar,et al.  Novel immunogenic baculovirus expressed virus-like particles of foot-and-mouth disease (FMD) virus protect guinea pigs against challenge. , 2013, Research in veterinary science.

[14]  J. Rushton,et al.  The economic impacts of foot and mouth disease – What are they, how big are they and where do they occur? , 2013, Preventive veterinary medicine.

[15]  Decheng Yang,et al.  Selection and characterization of an acid-resistant mutant of serotype O foot-and-mouth disease virus , 2013, Archives of Virology.

[16]  Lin Li,et al.  Use of baculovirus expression system for generation of virus-like particles: Successes and challenges , 2013, Protein Expression and Purification.

[17]  D. Stuart,et al.  Rational Engineering of Recombinant Picornavirus Capsids to Produce Safe, Protective Vaccine Antigen , 2013, PLoS pathogens.

[18]  A. Teixeira,et al.  Insect cells as a production platform of complex virus-like particles , 2013, Expert review of vaccines.

[19]  Yun Zhang,et al.  Development of a Foot-and-Mouth Disease Virus Serotype A Empty Capsid Subunit Vaccine Using Silkworm (Bombyx mori) Pupae , 2012, PloS one.

[20]  L. Pena,et al.  Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response. , 2011, Vaccine.

[21]  Zhiyong Li,et al.  FMD subunit vaccine produced using a silkworm-baculovirus expression system: protective efficacy against two type Asia1 isolates in cattle. , 2011, Veterinary microbiology.

[22]  M. Harmsen,et al.  Effect of thiomersal on dissociation of intact (146S) foot-and-mouth disease virions into 12S particles as assessed by novel ELISAs specific for either 146S or 12S particles. , 2011, Vaccine.

[23]  M. G. Mateu,et al.  A Single Amino Acid Substitution in the Capsid of Foot-and-Mouth Disease Virus Can Increase Acid Resistance , 2010, Journal of Virology.

[24]  Mauricio G. Mateu,et al.  A Single Amino Acid Substitution in the Capsid of Foot-and-Mouth Disease Virus Can Increase Acid Lability and Confer Resistance to Acid-Dependent Uncoating Inhibition , 2010, Journal of Virology.

[25]  Mauricio G. Mateu,et al.  Engineering Viable Foot-and-Mouth Disease Viruses with Increased Thermostability as a Step in the Development of Improved Vaccines , 2008, Journal of Virology.

[26]  Zhiyong Li,et al.  Expression of Foot-and-Mouth Disease Virus Capsid Proteins in Silkworm-Baculovirus Expression System and Its Utilization as a Subunit Vaccine , 2008, PloS one.

[27]  D. Rock,et al.  Comparative Genomics of Foot-and-Mouth Disease Virus , 2005, Journal of Virology.

[28]  T. Doel,et al.  Comparative immunogenicity of 146S, 75S and 12S particles of foot-and-mouth disease virus , 2005, Archives of Virology.

[29]  T. Doel,et al.  Thermal stability of foot-and-mouth disease virus , 2005, Archives of Virology.

[30]  B. Baxt,et al.  Foot-and-Mouth Disease , 2004, Clinical Microbiology Reviews.

[31]  E. Domingo,et al.  Evolution of foot-and-mouth disease virus. , 2003, Virus research.

[32]  T. Doel,et al.  FMD vaccines. , 2003, Virus research.

[33]  F. Sobrino,et al.  Foot-and-mouth disease virus: a long known virus, but a current threat. , 2001, Veterinary research.

[34]  F. Sobrino,et al.  Recombinant viruses expressing the foot-and-mouth disease virus capsid precursor polypeptide (P1) induce cellular but not humoral antiviral immunity and partial protection in pigs. , 1999, Virology.

[35]  F. Sobrino,et al.  Evidence of partial protection against foot-and-mouth disease in cattle immunized with a recombinant adenovirus vector expressing the precursor polypeptide (P1) of foot-and-mouth disease virus capsid proteins. , 1999, The Journal of general virology.

[36]  M. Karplus,et al.  Titration calculations of foot-and-mouth disease virus capsids and their stabilities as a function of pH. , 1998, Journal of molecular biology.

[37]  D I Stuart,et al.  Viral RNA modulates the acid sensitivity of foot-and-mouth disease virus capsids , 1995, Journal of virology.

[38]  A. Sen,et al.  Antibody response to 146S particle, 12S protein subunit and isolated VP1 polypeptide of foot-and-mouth disease virus type Asia-1. , 1994, Veterinary microbiology.

[39]  P. Barnett,et al.  Emergency vaccination against foot-and-mouth disease: rate of development of immunity and its implications for the carrier state. , 1994, Vaccine.

[40]  P. Hingley,et al.  Correlation of 140S antigen dose with the serum neutralizing antibody response and the level of protection induced in cattle by foot-and-mouth disease vaccines. , 1987, Vaccine.

[41]  D. Rowlands,et al.  Comparison of the antibodies elicited by the individual structural polypeptides of foot-and mouth disease and polio viruses. , 1979, The Journal of general virology.

[42]  K. Strohmaier,et al.  [Structure of foot-and-mouth disease virus]. , 1976, Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B.

[43]  F. Brown,et al.  Dissociation of Foot-and-Mouth Disease Virus into its Nucleic Acid and Protein Components , 1961, Nature.

[44]  F. Brown,et al.  Application of agar-gel diffusion analysis to a study of the antigenic structure of inactivated vaccines prepared from the virus of foot-and-mouth disease. , 1959, Journal of immunology.